Skip to main content
Top
Published in: Cancer Cell International 1/2020

01-12-2020 | Metastasis | Primary research

Genomic profiling of colorectal cancer with isolated lung metastasis

Authors: Nan Zhang, Jiabo Di, Zaozao Wang, Pin Gao, Beihai Jiang, Xiangqian Su

Published in: Cancer Cell International | Issue 1/2020

Login to get access

Abstract

Background

Metastasis is a major cause of failed colorectal cancer (CRC) treatment. While lung metastasis (LM) is observed in 10–15% of patients with CRC, the genetic mechanisms that cause CRC to metastasize to the lung remain unclear.

Methods

In this study, we employed whole exome sequencing (WES) of primary CRC tumors and matched isolated LM lesions to compare their genomic profiles. Comprehensive genomic analyses of five freshly frozen primary tumor lesions, five paired LM lesions, and matched non-cancerous tissues was achieved by WES.

Results

An integrated analysis of somatic mutations, somatic copy number alterations, and clonal structures revealed that genomic alterations were present in primary and metastatic CRCs with various levels of discordance, indicating substantial levels of intertumor heterogeneity. Moreover, our results suggest that the founder clone of the primary tumor was responsible for the formation of the metastatic lesion. Additionally, only a few metastasis-specific mutations were identified, suggesting that LM-promoting mutations might be pre-existing in primary tumors.

Conclusions

Primary and metastatic CRC show intertumor heterogeneity; however, both lesions were founded by the same clone. These results indicate that malignant clones contributing to disease progression should be identified during the genetic prognosis of cancer metastasis.
Appendix
Available only for authorised users
Literature
3.
go back to reference Cho JH, et al. The prognosis of pulmonary metastasectomy depends on the location of the primary colorectal cancer. Ann Thorac Surg. 2014;98(4):1231–7.PubMedCrossRef Cho JH, et al. The prognosis of pulmonary metastasectomy depends on the location of the primary colorectal cancer. Ann Thorac Surg. 2014;98(4):1231–7.PubMedCrossRef
4.
5.
go back to reference Chiang JM, et al. Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy. World J Surg Oncol. 2014;12:197.PubMedPubMedCentralCrossRef Chiang JM, et al. Rectal cancer level significantly affects rates and patterns of distant metastases among rectal cancer patients post curative-intent surgery without neoadjuvant therapy. World J Surg Oncol. 2014;12:197.PubMedPubMedCentralCrossRef
6.
go back to reference Limmer S, Unger L. Optimal management of pulmonary metastases from colorectal cancer. Expert Rev Anticancer Ther. 2011;11(10):1567–75.PubMedCrossRef Limmer S, Unger L. Optimal management of pulmonary metastases from colorectal cancer. Expert Rev Anticancer Ther. 2011;11(10):1567–75.PubMedCrossRef
7.
go back to reference Wang Z, et al. Survival benefit of palliative local treatments and efficacy of different pharmacotherapies in colorectal cancer with lung metastasis: results from a large retrospective study. Clin Colorectal Cancer. 2018;17(2):e233–55.PubMedCrossRef Wang Z, et al. Survival benefit of palliative local treatments and efficacy of different pharmacotherapies in colorectal cancer with lung metastasis: results from a large retrospective study. Clin Colorectal Cancer. 2018;17(2):e233–55.PubMedCrossRef
8.
go back to reference Liu J, et al. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1. Cancer Sci. 2019;110(1):135–46.PubMedCrossRef Liu J, et al. MORC2 promotes development of an aggressive colorectal cancer phenotype through inhibition of NDRG1. Cancer Sci. 2019;110(1):135–46.PubMedCrossRef
9.
go back to reference Liu J, et al. Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression. Oncogene. 2018;37(41):5477–91.PubMedCrossRef Liu J, et al. Forkhead box C1 promotes colorectal cancer metastasis through transactivating ITGA7 and FGFR4 expression. Oncogene. 2018;37(41):5477–91.PubMedCrossRef
10.
go back to reference Yamamoto T, et al. Loss of SMAD4 promotes lung metastasis of colorectal cancer by accumulation of CCR1+ tumor-associated neutrophils through CCL15-CCR1 axis. Clin Cancer Res. 2017;23(3):833–44.PubMedCrossRef Yamamoto T, et al. Loss of SMAD4 promotes lung metastasis of colorectal cancer by accumulation of CCR1+ tumor-associated neutrophils through CCL15-CCR1 axis. Clin Cancer Res. 2017;23(3):833–44.PubMedCrossRef
11.
go back to reference Li X, et al. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma. Mol Cancer. 2015;14:95.PubMedPubMedCentralCrossRef Li X, et al. High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma. Mol Cancer. 2015;14:95.PubMedPubMedCentralCrossRef
12.
go back to reference Fang LT, et al. Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis. Int J Oncol. 2014;44(1):211–21.PubMedCrossRef Fang LT, et al. Comprehensive genomic analyses of a metastatic colon cancer to the lung by whole exome sequencing and gene expression analysis. Int J Oncol. 2014;44(1):211–21.PubMedCrossRef
13.
go back to reference Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.CrossRefPubMed Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9(4):274–84.CrossRefPubMed
16.
17.
go back to reference Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.PubMedPubMedCentralCrossRef Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.PubMedPubMedCentralCrossRef
19.
20.
go back to reference Boeva V, et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics. 2012;28(3):423–5.PubMedCrossRef Boeva V, et al. Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data. Bioinformatics. 2012;28(3):423–5.PubMedCrossRef
21.
go back to reference Mermel CH, et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.PubMedPubMedCentralCrossRef Mermel CH, et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.PubMedPubMedCentralCrossRef
27.
go back to reference Cancer Genome Atlas, N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–7.CrossRef Cancer Genome Atlas, N. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487(7407):330–7.CrossRef
30.
go back to reference Xue R, et al. Variable intra-tumor genomic heterogeneity of multiple lesions in patients with hepatocellular carcinoma. Gastroenterology. 2016;150(4):998–1008.PubMedCrossRef Xue R, et al. Variable intra-tumor genomic heterogeneity of multiple lesions in patients with hepatocellular carcinoma. Gastroenterology. 2016;150(4):998–1008.PubMedCrossRef
31.
go back to reference Carvalho B, et al. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut. 2009;58(1):79–89.PubMedCrossRef Carvalho B, et al. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut. 2009;58(1):79–89.PubMedCrossRef
32.
go back to reference Postma C, et al. Gain of chromosome 20q is an indicator of poor prognosis in colorectal cancer. Cell Oncol. 2007;29(1):73–5.PubMedPubMedCentral Postma C, et al. Gain of chromosome 20q is an indicator of poor prognosis in colorectal cancer. Cell Oncol. 2007;29(1):73–5.PubMedPubMedCentral
33.
go back to reference Hossini AM, Eberle J. Apoptosis induction by Bcl-2 proteins independent of the BH3 domain. Biochem Pharmacol. 2008;76(11):1612–9.PubMedCrossRef Hossini AM, Eberle J. Apoptosis induction by Bcl-2 proteins independent of the BH3 domain. Biochem Pharmacol. 2008;76(11):1612–9.PubMedCrossRef
34.
35.
go back to reference Ogunbiyi OA, et al. Prognostic value of chromosome 1p allelic loss in colon cancer. Gastroenterology. 1997;113(3):761–6.PubMedCrossRef Ogunbiyi OA, et al. Prognostic value of chromosome 1p allelic loss in colon cancer. Gastroenterology. 1997;113(3):761–6.PubMedCrossRef
36.
go back to reference Xie T, et al. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations. PLoS ONE. 2012;7(7):e42001.PubMedPubMedCentralCrossRef Xie T, et al. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations. PLoS ONE. 2012;7(7):e42001.PubMedPubMedCentralCrossRef
37.
go back to reference Kovaleva V, et al. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing. Mol Cancer. 2016;15(1):63.PubMedPubMedCentralCrossRef Kovaleva V, et al. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing. Mol Cancer. 2016;15(1):63.PubMedPubMedCentralCrossRef
39.
go back to reference Wang L, et al. Rho GTPase Activating Protein 24 (ARHGAP24) silencing promotes lung cancer cell migration and invasion by activating beta-catenin signaling. Med Sci Monit. 2019;25:21–31.PubMedPubMedCentralCrossRef Wang L, et al. Rho GTPase Activating Protein 24 (ARHGAP24) silencing promotes lung cancer cell migration and invasion by activating beta-catenin signaling. Med Sci Monit. 2019;25:21–31.PubMedPubMedCentralCrossRef
40.
go back to reference Li J, et al. DIP2C expression in breast cancer and its clinical significance. Pathol Res Pract. 2017;213(11):1394–9.PubMedCrossRef Li J, et al. DIP2C expression in breast cancer and its clinical significance. Pathol Res Pract. 2017;213(11):1394–9.PubMedCrossRef
41.
42.
go back to reference Wang Z, et al. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells. Exp Cell Res. 2017;357(1):1–8.PubMedCrossRef Wang Z, et al. Down-regulation of LRP1B in colon cancer promoted the growth and migration of cancer cells. Exp Cell Res. 2017;357(1):1–8.PubMedCrossRef
43.
go back to reference Chen H, et al. Association of LRP1B mutation with tumor mutation burden and outcomes in melanoma and non-small cell lung cancer patients treated with immune check-point blockades. Front Immunol. 2019;10:1113.PubMedPubMedCentralCrossRef Chen H, et al. Association of LRP1B mutation with tumor mutation burden and outcomes in melanoma and non-small cell lung cancer patients treated with immune check-point blockades. Front Immunol. 2019;10:1113.PubMedPubMedCentralCrossRef
44.
go back to reference Rajendran BK, Deng CX. A comprehensive genomic meta-analysis identifies confirmatory role of OBSCN gene in breast tumorigenesis. Oncotarget. 2017;8(60):102263–76.PubMedPubMedCentralCrossRef Rajendran BK, Deng CX. A comprehensive genomic meta-analysis identifies confirmatory role of OBSCN gene in breast tumorigenesis. Oncotarget. 2017;8(60):102263–76.PubMedPubMedCentralCrossRef
45.
go back to reference Doherty JA, et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomark Prev. 2010;19(1):245–50.CrossRef Doherty JA, et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiol Biomark Prev. 2010;19(1):245–50.CrossRef
46.
go back to reference Rangel R, et al. Identification of new tumor suppressor genes in triple-negative breast cancer. Cancer Res. 2017;77(15):4089–101.CrossRefPubMed Rangel R, et al. Identification of new tumor suppressor genes in triple-negative breast cancer. Cancer Res. 2017;77(15):4089–101.CrossRefPubMed
48.
go back to reference McGranahan N, et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci Transl Med. 2015;7(283):283ra54.PubMedPubMedCentralCrossRef McGranahan N, et al. Clonal status of actionable driver events and the timing of mutational processes in cancer evolution. Sci Transl Med. 2015;7(283):283ra54.PubMedPubMedCentralCrossRef
49.
go back to reference Matano M, et al. Modeling colorectal cancer using CRISPR–Cas9-mediated engineering of human intestinal organoids. Nat Med. 2015;21(3):256–62.PubMedCrossRef Matano M, et al. Modeling colorectal cancer using CRISPR–Cas9-mediated engineering of human intestinal organoids. Nat Med. 2015;21(3):256–62.PubMedCrossRef
51.
go back to reference Kim TM, et al. Subclonal genomic architectures of primary and metastatic colorectal cancer based on intratumoral genetic heterogeneity. Clin Cancer Res. 2015;21(19):4461–72.PubMedCrossRef Kim TM, et al. Subclonal genomic architectures of primary and metastatic colorectal cancer based on intratumoral genetic heterogeneity. Clin Cancer Res. 2015;21(19):4461–72.PubMedCrossRef
52.
go back to reference Wei Q, et al. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis. Ann Oncol. 2017;28(9):2135–41.PubMedPubMedCentralCrossRef Wei Q, et al. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis. Ann Oncol. 2017;28(9):2135–41.PubMedPubMedCentralCrossRef
55.
go back to reference Werner-Klein M, et al. Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma. Nat Commun. 2018;9(1):595.PubMedPubMedCentralCrossRef Werner-Klein M, et al. Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma. Nat Commun. 2018;9(1):595.PubMedPubMedCentralCrossRef
Metadata
Title
Genomic profiling of colorectal cancer with isolated lung metastasis
Authors
Nan Zhang
Jiabo Di
Zaozao Wang
Pin Gao
Beihai Jiang
Xiangqian Su
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2020
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-020-01373-x

Other articles of this Issue 1/2020

Cancer Cell International 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine